Capecitabine Tablets
Description
- 产品描述
-
Product Information
Product Name: Capecitabine Tablets
Specification: 0.5g
Active Ingredient: Capecitabine
Description: Biconvex, rectangular peach-colored film-coated tablets with white cores when the coating is removed.
Indications:
◆ Colorectal Cancer
First-line therapy: Monochemotherapy or combination chemotherapy (e.g., combined with oxaliplatin) for metastatic colorectal cancer.
Adjuvant postoperative therapy: Adjuvant chemotherapy after resection of Dukes' C colon cancer to reduce recurrence risk.
◆ Breast Cancer
Adjuvant therapy: For metastatic breast cancer resistant to or recurrent after paclitaxel and anthracycline treatment.
Combination therapy: Co-administered with docetaxel and other agents to enhance therapeutic efficacy.
◆ Gastric and Esophageal Cancer
Palliative treatment for advanced or metastatic gastric and esophageal cancer, especially for patients intolerant to intravenous chemotherapy.
FAQs
What main products does Baotai Pharmaceutical supply?
Which countries and regions do you mainly export to?
Does your company have international GMP qualification support?
Can you help complete local drug registration in target countries?
What therapeutic areas do your human medicines focus on?
Do you cooperate with formal domestic pharmaceutical manufacturers?
Capecitabine Tablets
OUR SERVICE
We offers a wealth of product support resources, including a range of technical and downloadable product manuals to product certifications.
Documentation Contact UsRelated Products
The content is currently being updated……
Send E-mail
Phone/Whatsapp
+86-15230180709 (Pharmaceuticals)
+86-18603110901 (Medical Devices)
Address
Linping District, Hangzhou City, Zhejiang Province, China
WHO WE ARE
Baotai (Hangzhou) Pharmaceutical Co., Ltd. is a comprehensive multinational pharmaceutical and healthcare enterprise with nearly 20 years of industry heritage.
